SCOPUS 정보 검색 플랫폼

Blood

Volumn 119, Issue 5, 2012, Pages 1099-1100

HIT: Treatment easier, prevention harder

(1) Warkentin, Theodore E a

a MCMASTER UNIVERSITY (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 O, 3 O DESULFATED HEPARIN; ARGATROBAN; DABIGATRAN; FONDAPARINUX; HEPARIN; HEPARIN DERIVATIVE; LEPIRUDIN; RIVAROXABAN; UNCLASSIFIED DRUG;

ANTICOAGULANT THERAPY; BLEEDING; DRUG COST; DRUG MONITORING; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; HYPERCOAGULABILITY; IMMUNOGENICITY; LABORATORY TEST; NOTE; OFF LABEL DRUG USE; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; STROKE; THROMBOSIS PREVENTION;

EID: 84856589274 PISSN: 00064971 EISSN: 15280020 Source Type: Journal
DOI: 10.1182/blood-2011-11-391284 Document Type: Note

Times cited : (14)

References (10)

1
- 84856600313
- Heparin-induced thrombocytopenia: In vitro studies on the interaction of dabigatran, rivaroxaban, and low-sulfated heparin, with platelet factor 4 and anti-PF4/heparin antibodies
- Krauel K, Hackbarth C, Fürll B, Greinacher A. Heparin-induced thrombocytopenia: in vitro studies on the interaction of dabigatran, rivaroxaban, and low-sulfated heparin, with platelet factor 4 and anti-PF4/heparin antibodies. Blood. 2012;119(5):1248-1255.
- (2012) Blood , vol.119 , Issue.5 , pp. 1248-1255
- Krauel, K.¹ Hackbarth, C.² Fürll, B.³ Greinacher, A.⁴

2
- 0030281338
- A 14-year study of heparin-induced thrombocytopenia
- DOI 10.1016/S0002-9343(96)00258-6, PII S0002934396002586
- Warkentin TE, Kelton JG. A 14-year study of heparin-induced thrombocytopenia. Am J Med. 1996;101:502-507. (Pubitemid 126335970)
- (1996) American Journal of Medicine , vol.101 , Issue.5 , pp. 502-507
- Warkentin, T.E.¹ Kelton, J.G.²

3
- 82755193935
- How I diagnose and manage HIT
- Warkentin TE. How I diagnose and manage HIT. Hematology Am Soc Hematol Educ Program. 2011;2011:143- 149.
- (2011) Hematology Am Soc Hematol Educ Program , vol.2011 , pp. 143-149
- Warkentin, T.E.¹

4
- 45949103154
- Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)
- DOI 10.1378/chest.08-0677
- Warkentin TE, Greinacher A, Koster A, Lincoff AM. Treatment and prevention of heparin-induced thrombocytopenia. American College of Chest Physicians evidence-based clinical practice guidelines (8th ed). Chest. 2008; 133(6 Suppl):340S-380S. (Pubitemid 351892970)
- (2008) Chest , vol.133 , Issue.6 SUPPL. 6
- Warkentin, T.E.¹ Greinacher, A.² Koster, A.³ Lincoff, A.M.⁴

5
- 43949108861
- The direct thrombin inhibitor hirudin
- Greinacher A, Warkentin TE. The direct thrombin inhibitor hirudin. Thromb Haemost. 2008;99(5):819- 829.
- (2008) Thromb Haemost , vol.99 , Issue.5 , pp. 819-829
- Greinacher, A.¹ Warkentin, T.E.²

6
- 79960644200
- HIT paradigms and paradoxes
- Warkentin TE. HIT paradigms and paradoxes. J Thromb Haemost. 2011;9(Suppl 1):105-117.
- (2011) J Thromb Haemost , vol.9 , Issue.SUPPL. 1 , pp. 105-117
- Warkentin, T.E.¹

7
- 51249107287
- Rivaroxaban - An oral, direct factor Xa inhibitor - has potential for the management of patients with heparin-induced thrombocytopenia
- Walenga JM, PrechelM,Jeske WP, et al. Rivaroxaban - an oral, direct factor Xa inhibitor - has potential for the management of patients with heparin-induced thrombocytopenia. Br J Haematol. 2008;143(1):92-99.
- (2008) Br J Haematol , vol.143 , Issue.1 , pp. 92-99
- Walenga, J.M.¹ Prechel, M.² Jeske, W.P.³

8
- 18844385757
- Successful treatment of heparin induced thrombocytopenia (HIT) with fondaparinux
- Kuo KHM, Kovacs MJ. Successful treatment of heparin induced thrombocytopenia (HIT) with fondaparinux. Thromb Haemost. 2005;93(5):999-1000. (Pubitemid 40691563)
- (2005) Thrombosis and Haemostasis , vol.93 , Issue.5 , pp. 999-1000
- Kuo, K.H.M.¹ Kovacs, M.J.²

9
- 78049443734
- Fondaparinux: Does it cause HIT? Can it treat HIT?
- Warkentin TE. Fondaparinux: does it cause HIT? can it treat HIT? Exp Rev Hematol. 2010;3(5):567-581.
- (2010) Exp Rev Hematol , vol.3 , Issue.5 , pp. 567-581
- Warkentin, T.E.¹

10
- 82755189078
- Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: A 30-month, 16-patient case series
- Warkentin TE, Pai M, Sheppard JI, Schulman S, Spyropoulos AC, Eikelboom JW. Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series. J Thromb Haemost. 2011;9(12):2389-2396.
- (2011) J Thromb Haemost , vol.9 , Issue.12 , pp. 2389-2396
- Warkentin, T.E.¹ Pai, M.² Sheppard, J.I.³ Schulman, S.⁴ Spyropoulos, A.C.⁵ Eikelboom, J.W.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.